We previously isolated and characterized a cDNA clone specifically expressed in neurons R3 to R8 and R14 of the Aplysia abdominal ganglion (Nambu, J. R., R. Taussig, A. C. Mahon, and R. H. Scheller (1983) Cell 35: 47-56). The cDNA nucleotide sequence and the inferred protein amino acid sequence suggest that this gene encodes the precursor for neuroactive peptides used by these cells. Peptides corresponding to three regions of the precursor were synthesized, coupled to a protein carrier, and used to generate antibodies. These antibodies stain a set of cell bodies, R3 to R14, and their processes in the abdominal ganglion; no other cells in the nervous system or the periphery are immunoreactive.
The biologically active peptides are a far more diverse class of neurochemical messengers than the classical transmitters. These molecules function as transmitters, modulators, and hormones in the central and peripheral nervous systems of vertebrate and invertebrate species (e.g., Kreiger et al., 1983) . Neuropeptides can coexist in the same neuron as classical transmitters but, unlike classical transmitters, are often active at a greater distance from the site of release. The activities generated by peptides typically have slower onsets and longer durations than small molecule transmitters, such as acetylcholine or GABA. The gastropod mollusc Aplysia californica is especially suitable for studying neuropeptides (Scheller et al., 1982) .
The central nervous system of Aplysia contains about 20,000 neurons organized into four pairs of symmetrical ganglia and a single asymmetrical abdominal ganglion. The abdominal ganglion governs a number of reflex and fixed action patterns (Kandel, 1976; Kandel and Schwartz, 1982) . The neuroendocrine bag cells govern a behavioral repertoire associated with egg laying. Other neurons of the ganglion are involved in the central control of visceral functions.
We have isolated and characterized genes encoding five different precursors or families of precursors which give rise to neuropeptides found in the abdominal ganglion. These include the genes encoding the egglaying hormone (ELH), the small cardioactive peptide B (Morris et al., 1982) , and genes expressed in the neuroendocrine cells Lll, RX, and R3 to R14 ( Fig. 1) (Scheller et al. 1982 (Scheller et al. , 1983 Nambu et al., 1983 Nambu et al., 1983) . Processing of the precursor is not completely understood;
however, a minimum of three cleavages is thought to occur. The first removes the signal sequence and is followed by cleavage at two paired basic residues as illustrated in Figure 2 . Further cleavages probably occur at single arginine residues; which of these residues actually serve as cleavage sites is not yet clear (Aswad, 1978; Gainer and Wollberg, 1974; Loh et al, 1977; Nambu et al., 1983; R. R. Kaldany, M. Schaefer, and R. H. Scheller, unpublished data The amino acid sequence of the precursor was obtained from the only open reading frame in the cDNA clone long enough to encode a protein of the correct molecular weight (Nambu et al., 1983) . The stippled regions are hydrophobic amino acids ('a), an S below the precursor indicates a cysteine residue, diagonal lines are histidine residues (a), and horizontal lines are proline @). The large arrow is the position of cleavage of the signal sequence, and the small arrows indicate the positions of the two dibasic residues that serve as proteolytic processing sites. The three peptides synthesized in this study are bracketed above the sequence. Peptide Z extends from residues 21 to 36, peptide ZZ from residues 52 to 63, and peptide ZZZ from residues 100 to iO8. neuropeptides are likely to be packaged as extracellular messengers (Price and McAdoo, 1981) . By following "large white" processes emanating from these cells and by HRP injections, it appears that R3 to R14 send processes to the efferent vein of the gill at the base of the auricle and to the vasculature near the abdominal ganglion (Price and McAdoo, 1979) . Evidence is accumulating that glycine and one or more of the neuropeptides modulate the rhythm, rate, and force of the heartbeat as well as constriction of the arteries (Roza et al., 1980; Sawada et al., 1981a, b) .
To better understand the function of the R3 to R14 neurons, we have begun a molecular analysis of the secretory products. We have synthesized peptides specified by the nucleotide sequence of the cDNA clone specific to R3 to R14. Polyclonal antibodies to these peptides were generated by coupling the molecules to protein carriers and immunizing rabbits. This report presents the results of immunohistochemical studies using polyclonal antibodies to three distinct regions of the precursor (Fig. 2) ortho-chlorobenzyloxycarbonyl for lysine; and 2,6dichlorobenzyl for tyrosine.
All couplings were performed using a 2.5 M excess of tbutoxycarbonyl amino acid and dicyclohexylcarbodiimide over the number of milliequivalents of amino acid on the resin. In the case of asparagine and glycine, a 2.5 M excess of the amino acid, dicyclohexylcarbodiimide, and N-hydroxy triazole was used. All couplings were greater than 99% complete as determined by reaction of the resin with ninhvdrin. Three peptides were synthesized corresponding to amino acid residues 21 to 36, peptide I (Ala-Trp-SerGlu-Glu-Val-Phe-Asn-Asn-Thr-Asn-Val-Glv-Asn-Glu-Leu):
52 to 63, peptide II (Glu-Ala-~lu-dlu-Pro-Ser-Ala-Phe-ll;let-Thr-A~~-Leu); and 100 to 108, peptide III (Tyr-Gly-Gly-Gly-His-Leu-Ser-Asp-Ala) (Fig.  2) Peptides used in these experiments were not further purified since they all contained greater than 90% of the desired product.
Conjugation of the peptides to carrier proteins. The peptides to which the cysteine had been added were conjugated to bovine serum albumin or bovine gamma globulin using succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) or m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) (both Pierce) as described (Yoshitake et al., 1979) . Briefly, 10 mg of the carrier protein were dissolved in 2 ml of PBS, pH 7.4, and combined with 5 mg of crosslinker dissolved in 500 ~1 of dimethylformamide.
After an hour, the conjugate was separated from unreacted crosslinker by gel filtration on a G-25 column in 0.1 M phosphate, pH 6.0. The peptide to be conjugated was dissolved in 0.1 M borate, pH 9.1, and reduced with NaBH4 (100 ~1 of 0.1 M stock). After 5 min, the pH of the borate solution was lowered to 1 with 1 M HCl to remove any excess NaBH, then raised to pH 6 with 1 M NaOH and combined with the carrier-crosslinker conjugate. After incubating for an additional hour, the carrier-peptide conjugate was desalted on a G-25 column in 0.1 M NHIHC03. The degree of conjugation was quantitated by comparing the composition of the carrier protein before and after reaction with the peptide. The conjugates used in this study all contained between 15 and 25 peptides per carrier molecule (Fig. 3) . Antibody oroduction. New Zealand White rabbits were initiallv injected with i.5 ml/rabbit of peptide carrier conjugate at a concentration of 0.125 pg/ml in PBS plus Freund's complete adjuvant. Three boosts were administered at 2-week intervals followed by a final boost 1 month later. Rabbits were bled, and blood was allowed to congeal overnight at 4"C, followed by centrifugation at 10,000 rpm for 30 min to obtain the supernatant antisera. suggests that the abdominal ganglion cells do not release any of the peptides directly to these ganglia. Many abdominal ganglion cells and processes were observed to react with the antibodies. Figure 4 shows an experiment in which alternate sections of a single ganglion were stained with antibodies to the three different regions of the precursor and with a control. In each case, immunoreactive material is observed in the cytoplasm but not the nuclei of two right upper quadrant cells; no staining is seen in the control slide. This demonstrates that the protein sequence inferred from the nucleotide sequence of the cDNA clone is correct. The immunoreactive material may represent the precursor protein, various cleavage products, or both. The experiment suggests that all three portions of the precursor are present in the immunoreactive cell bodies at approximately equal concentrations. This result is consistent with our RNA blotting experiments, which revealed a prominent transcript in the abdominal ganglion and not in the head ganglia (Nambu et al., 1983) . These two sets of experiments conclusively demonstrate that the abdominal ganglion is the primary expression site of this neuropeptide gene and that very few or no cells in the rest of the nervous system express the gene.
The cell bodies of R3 to R14 have an efficient uptake system for the amino acid glycine which may be used as a chemical messenger by these cells (Price et al., 1979) . The presence of the three portions of the precursor and glycine in the same cell bodies suggests that all of these molecules have the opportunity to be packaged into the same vesicles for co-release.
The distribution of immunoreactive cells and processes in the CNS. Whole mount preparations and sectioned tissue were used to localize the cell bodies and processes containing immunoreactive material. Figure 5 shows the results of a series of whole mount preparations using juvenile animals. Since these organisms were collected from natural populations, their age is unknown but is estimated to be between 40 and 80 days postmetamorphosis. Animals at this stage of development have a thin sheath of connective that allows the antibodies to penetrate to the cell bodies and processes (McAllister et al., 1983) . Results obtained with the whole mounts are not necessarily valid for adults; however, conclusions reached from sectioned adult tissue and juvenile whole mounts are generally consistent. R14 is clearly visible as an intensely staining cell in the right lower quadrant near the branchial nerve. A large process emanates from the cell, projecting rostrally. This process trifurcates, sending branches up the pleural abdominal connective, down the branchial nerve, and to the abdominal ganglion artery. Three other cells are seen, two on the ventral surface and one on the dorsal surface. Each of these cells sends a process to the periphery via the branchial nerve. A host of fine varicose processes was particularly prominent in the right hemiganglion. These observations, in conjunction with electron microscopic ultrastructural evidence (Price and McAdoo, 1979) , suggest that secretory products may be released at these sites. The processes projecting up the pleural abdominal connective also contain l-to 2-pm varicosities along their length.
The situation in adults is similar; while considerable variability, which we attribute to polymorphism, was present, a more complete complement of R3 to R13 cells appears to be present (Fig. 6 ). These cells are identifiable by virtue of their large size and relative position to other cells of the abdominal ganglion. The cell bodies of these neurons stain intensely, while the nuclei are devoid of detectable immunoreactivity. R14 was occasionally observed as a pair of large immunoreactive cells rather than the single neuron thought to occupy this region of the ganglion. The right upper quadrant neurons, R3 to R8, were plainly visible in most animals. As few as three to as many as six cells were visible, depending on the individual. Neurons R9 to R13 were also somewhat variable in number and position.
Serial reconstructions of the whole abdominal ganglion indicate that cells of the appropriate size and position to be the "white cells," R3 to R14, all contain immunoreactivity to the antibodies we have generated and, therefore, all express products of the gene we have cloned.
The presence of immunoreactivity in frozen sections through the abdominal ganglion clearly demonstrates that processes traverse and terminate in the connective tissue sheath (Fig. 6) . The vascularized sheath is used as a neuroendocrine release site by other neurons, such as the bag cells (Frazier et al., 1967) . This mechanism of release is an effective means of delivering peptide to both the circulatory system and the neurons of the abdominal ganglion. This would allow the excitability of central neurons to be modulated synchronously with changes in the contractibility, for example, of peripheral tissues. The coordination of central and peripheral actions through neuroendocrine processes of this type seems to be a general feature of both invertebrate and vertebrate species.
Immunoreactive processes in the periphery.
An array of peripheral tissues was examined for immunoreactivity, including the gut, buccal mass, body wall muscle, reproductive tract, and heart. No tissues except the heart and vasculature showed staining above background. As shown in Figure 7 , the efferent vein of the gill and the aorta close to the ganglion both contain immunoreactive processes. As described by Price and McAdoo (1979) , the large axons that exit the ganglion via the branchial nerve terminate on the efferent vein at the base of the auricle. These axons branch many times and are seemingly interlaced with constitutive tissue fibers. In addition, a large number of varicosities is present in this region. Processes ending on the anterior aorta exit the ganglion via the vulvar nerve and seem to run largely parallel to the myofibrils comprising the wall of the hemolymph vessel. Processes from R14 also end on the abdominal ganglion artery at the base of the ganglion near the midline. The varicosities observed on these terminal endings are likely to be sites of messenger release. The distribution of these varicosities is consistent with the notion that R3 to R14 are involved in modulating cardiac output and vasoconstriction by releasing chemical messengers directly onto or near appropriate muscle fibers.
Discussion
Recombinant DNA techniques are becoming increasingly useful in the characterization of functionally important neuronal proteins. The general approach involves determining the nucleotide sequence of neuron-specific cDNA clones and using this information to synthesize peptides to which antibodies can be raised. As demonstrated in this report and by others (Rosenfield et al., 1983; Sutcliffe et al., 1983) , the antibodies can then be used to map out positions of immunoreactive cell bodies and processes.
Three antibodies, each generated to a different region of the protein encoded by the cDNA clone, specifically stain neurons R3 to R14 of the abdominal ganglion and no other cell bodies in the CNS or peripheral tissue. The R3 to R14 neurons innervate the vascularized sheath, the efferent vein of the gill, the abdominal ganglion artery, and the aorta. Their processes are studded with varicosities which may function as vesicle storage and release sites.
R3 to R14 specifically uptake and package free glycine into vesicles (Price et al., 1979) . Bath application of glycine increases the force and frequency of the Aplysia heart beat, resulting in increased blood pressure. When applied to the artery, glycine causes a small depolarization. The R3 to R14 neurons, at least in dissected ganglion preparations, have a spontaneous and regular firing pattern. These observations, in conjunction with our immunocytochemical data, suggest that these cells use glycine and neuropeptides to exert tonic control over the circulation. It is not clear why the R3 to R14 peptides and glycine might be utilized centrally as the distribution of axon endings implies. It might be useful to exert control over the circulatory system both centrally and peripherally.
The R3 to R14 messengers may modulate output of central neurons, changing the firing pattern of a given cell and peripherally modulating the effect of that cell on its target. Alternatively, peripheral effects may be independent of central control such that modulation is exercised by direct action on the myogenic pacemaker system. Different transmitter candidates presumably exert complementary effects on postsynaptic targets. Until more is known about the function of the cells and the roles of individual transmitters, the significance of coexistence remains unresolved. Glycine may act as a conventional transmitter to elicit rapid but short duration changes in target cells and tissues, while the peptides exert complementary longer term responses of slower onset. It also must be determined whether glycine and the cleavage products of the peptide precursor are released from the same terminals or if they coexist in the same vesicles. The effect of glycine is probably restricted to short range interactions due to the relatively high circulating levels of the amino acid (Ilife et al, 1977; Price and McAdoo, 1979) . However, the peptides could have hormonal influences over target tissues eliciting responses some distance from their site of release. We hope the antibody reagents reported here and the accessibility of the Aplysiu nervous sytem will make possible the resolution of these and other issues of central importance to understanding how extracellular messengers are used by the nervous system.
